International Journal of Radiation Oncology*Biology*Physics
Volume 108, Issue 1, 1 September 2020, Pages 225-226
The Abscopal EffectStereotactic Body Radiation Therapy (SBRT) Combined with Immune Check-Point Inhibition (ICI) in Advanced Lung Cancer: Which Metastatic Site Should Be Irradiated to Induce Immunogenic Cell Death?
References (8)
- et al.
Lung stereotactic body radiation therapy and concurrent immunotherapy: A multicenter safety and toxicity analysis
Int J Radiat Oncol Biol Phys.
(2020) - et al.
State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours—a German radiation oncology survey
Eur J Cancer
(2019) - et al.
Stereotactic ablative radiation therapy induces systemic differences in peripheral blood immunophenotype dependent on irradiated site
Int J Radiat Oncol Biol Phys
(2018) - et al.
Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC
New Engl J Med
(2018)
There are more references available in the full text version of this article.
Cited by (15)
Combining radiation therapy with immune checkpoint blockade for the treatment of small cell lung cancer
2023, Seminars in Cancer BiologyPromising Stereotactic Body Radiotherapy in NSCLC
2020, Journal of Thoracic OncologyFerroptosis-mediated immune responses in cancer
2023, Frontiers in Immunology
Disclosures: none.
© 2020 Elsevier Inc. All rights reserved.